Affordable Access

Publisher Website

Cardiac remodeling in coronary artery disease

Authors
Publisher
Elsevier Inc.
Publication Date
Volume
93
Issue
9
Identifiers
DOI: 10.1016/j.amjcard.2004.01.002
Disciplines
  • Medicine

Abstract

Abstract Cardiac remodeling is a central mechanism of heart failure progression in patients with coronary artery disease (CAD). The remodeling effect of β-blockade with carvedilol has been studied in patients with left ventricular dysfunction after myocardial infarction and in patients with chronic heart failure of ischemic etiology. Carvedilol has been found to prevent progressive adverse ventricular remodeling in both conditions. This effect is concordant with the improvement in long-term clinical outcomes established for carvedilol in such patients. Thus, ventricular remodeling appears to be an important treatment target in patients with CAD and is likely to mediate at least part of the clinical improvement achieved with carvedilol.

There are no comments yet on this publication. Be the first to share your thoughts.

Statistics

Seen <100 times
0 Comments

More articles like this

Cardiac remodeling in coronary artery disease.

on The American Journal of Cardio... May 06, 2004

Vascular remodeling in coronary artery disease.

on Journal of Cardiovascular Phar... 1994

Shear stress and vascular remodeling: study of car...

on The Journal of heart and lung... April 2002
More articles like this..